-The Hindu Carbon credit system paying rich dividends to farmers too Chennai: In a silent afforestation campaign, a private company has successfully raised more than a million trees on private lands in five districts in the State and recorded a survival rate of 90 per cent. Giving details to The Hindu about the successful planting of saplings and raising them to trees, A. Joseph Rexon, Director, TIST Tree Planting India programme, said it...

-The Telegraph JALNA AND AHMEDNAGAR: Sakharam Misal is frank. Water, he says, is big business. In Jalna district, which has run out of water, the man in his late 50s is among the most sought after. He runs a water tanker business and sells water to the thirsty millions. Misal's cellphone keeps ringing with desperate calls for water. His tankers are booked in advance and the waiting list stretches over a week. Drought,...

KEY TRENDS   • According to National Sample Survey report no. 583: Persons with Disabilities in India, the percentage of persons with disability who received aid/help from Government was 21.8 percent, 1.8 percent received aid/help from organisation other than Government and another 76.4 percent did not receive aid/ help *8   • As per National Family Health Survey-4 (NFHS-4), the Under-five Mortality Rate (U5MR) was 57.2 per 1,000 live births (for the non-STs it was 38.5)...

-The Financial Express A patent law that is transparent, based on principles of good science & encourages innovation is in India's interest In 500 BC, in the Greek city of Sybaris, it was proclaimed that "encouragement was held out to all who should discover any new refinement in luxury, the profits arising from which were secured to the inventor by patent for the space of a year." England followed with the Statute...

-The Hindu   "The court has recognised the right of patients to access affordable medicines over profits for big pharma companies" It was celebration time for health activists and civil society groups after the Supreme Court delivered its judgment dismissing Swiss multinational company Novartis' appeal for patent for its anti-cancer medicine imatinib mesylate or Gleevec. "We are happy that the apex court has recognised the right of patients to access affordable medicines over profits...